Zsuzsanna Bagó-Horváth

Medical University of Vienna — Austria

Biochemistry, Genetics and Molecular Biology · Life Sciences

44h-index7.8kcitations334works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(63), HER2/EGFR in Cancer Research(52), Advanced Breast Cancer Therapies(43), Radiomics and Machine Learning in Medical Imaging(40), Cancer Genomics and Diagnostics(39)

Publications330 total

Uptake Patterns of [18F]Fluoroestradiol PET/MRI in Benign Breast Lesions and Molecular Breast Cancer Subtypes
Cancers·2026Open Access
ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34
The Breast·2025Open Access
Systematic mapping of human tissue microanatomy reveals age-associated remodeling and resilience
2025· 1 citedOpen Access
LesiOnTime - Joint Temporal and Clinical Modeling for Small Breast Lesion Segmentation in Longitudinal DCE-MRI
Lecture notes in computer science·2025Open Access
Temporal Representation Learning of Phenotype Trajectories for pCR Prediction in Breast Cancer
arXiv (Cornell University)·2025Open Access
Temporal Representation Learning of Phenotype Trajectories for pCR Prediction in Breast Cancer
Lecture notes in computer science·2025
New Perspectives in the Management of Triple-Negative Breast Cancer
Breast Care·2025· 1 citedOpen Access
HER2/CEP17 ratio predicts residual cancer burden after neoadjuvant dual HER2 blockade: real-world data in patients with primary HER2-amplified breast cancer
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2025· 1 citedOpen Access
LesiOnTime -- Joint Temporal and Clinical Modeling for Small Breast Lesion Segmentation in Longitudinal DCE-MRI
arXiv (Cornell University)·2025Open Access
Abstract P2-01-24: Immune activation of tumor cells and microenvironment as assessed by PD-L1 expression and interferon gamma signaling predict long term disease-free and overall survival: Results of the prospective randomized neoadjuvant ABCSG 34 trial
Clinical Cancer Research·2025
Abstract P4-01-26: The Xpert® Breast Cancer Insight test predicts distant recurrence and overall survival in estrogen receptor-positive, HER2-negative early breast cancer: A validation study in ABCSG Trial 8
Clinical Cancer Research·2025
Abstract P2-03-30: Association of ctDNA in patients with long-term outcome of breast cancer patients undergoing neoadjuvant treatment in the randomized ABCSG 34 clinical trial
Clinical Cancer Research·2025
Abstract PS3-03: Vaccination with MUC-1-targeting tecemotide improves Survival of patients receiving neo-adjuvant chemotherapy for early breast cancer: Results from the Prospective Randomized ABCSG 34 Trial
Clinical Cancer Research·2025
Prospective randomized phase II trial to assess the efficacy and safety of neo-adjuvant olaparib/carboplatin (OC) in comparison to docetaxel/epirubicin/cyclophosphamide (TAC) in patients with early triple-negative breast cancer (TNBC) with homologous recombination deficiency (HRD): Primary results from the ABCSG 45 trial.
Journal of Clinical Oncology·2025· 2 cited
Risk Assessment Using Gene Expression Profiling Correlates with Clinical Prognosis Estimation in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer
Breast Care·2025Open Access
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer
British Journal of Cancer·2025· 3 citedOpen Access
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
Nature Cancer·2025· 5 citedOpen Access
HER2 and HER3 expression during neoadjuvant treatment of HER2‐negative early breast cancer: potential for biomarker‐driven sequencing of T‐DXd and HER3‐DXd
Cancer Communications·2025· 2 citedOpen Access
CT-based radiomic prognostic vector (RPV) predicts survival and stromal histology in high-grade serous ovarian cancer: an external validation study
European Radiology·2024· 3 citedOpen Access
The challenge of accounting for less frequently consumed foods with a high impact on nutrient intake estimates using the EFSA Comprehensive Food Consumption Database: The example of preformed vitamin A
EFSA Journal·2024Open Access
page 1 of 17Next →

Frequent Co-authors

Peter Dubsky(17), Rupert Bartsch(16), Margaretha Rudas(15), Michael Gnant(14), Katja Pinker(14), Thomas H. Helbich(13), Florian Fitzal(10), Pascal Baltzer(10), Martin Filipits(9), Christian F. Singer(9), Wolfgang Bogner(9), Anna S. Berghoff(8), Thomas Szekeres(8), Michael Weber(7), Stephan Gruber(7), Siegfried Trattnig(7), Guenther G. Steger(7), Karin Dieckmann(6), Matthias Preusser(6), Christoph Zielinski(6)